Lung Cancer Screening & Treatment: What Comes Next?
The pulmonology and oncology expert panel returns for another discussion on lung cancer treatment challenges presented by the pandemic—and how the field can recover.
Read More
ASPC 2021 Virtual Summit on CVD Prevention Taking Place July 23-25
The virtual sessions will cover a litany of topics in the greater spectrum of cardiovascular disease prevention and care.
Gil Melmed, MD: Biologics for Inflammatory Bowel Disease
Potential for Cure with Gene Therapy and Final Thoughts
C. Difficile: Barriers Treating With FMT
Making Strides in the Management of C. Difficile
Emerging Treatment Options for C. Difficile Infections
The Cost of Gene Therapy Versus Alternatives
Gene Therapy Toxicities and Management
Final Thoughts on the Management of Atopic Dermatitis in Patients of Color
Importance of Communication Between Patients and Physicians
Promising Developments for Gene Therapy
Access to Dupilumab for the Management of Atopic Dermatitis
Safety Profile of Dupilumab in managing Atopic Dermatitis
Fecal Microbiota Transplantation for C. Difficile Infections
Gene Therapy Strategies for Sickle Cell Disease
Role of Crizanlizumab and Voxelotor in SCD
Dupilumab for Management of Atopic Dermatitis in Patients of Color
Topical and Systemic Agents to Manage Atopic Dermatitis
Preventing/Treating C. Difficile: Unmet Needs
C. Difficile Treatment: Bezlotoxumab
Patients Considered for HSCT
Indications and Adverse Effects of Blood Transfusions
Gentle Cleansing Routine to Help Manage Atopic Dermatitis
Lifestyle Modification to Manage AD in Patients With Skin of Color
Multidisciplinary Management for the Treatment of DTC
Approaching Treatment of Low-Volume DTC
Understanding Sequencing and What to Look for in DTC
C. Difficile Treatment: Fidaxomicin
Choosing Between Vancomycin and Fidaxomicin for C. Difficile Infections
